ESC/EAS Guidelines for the management of dyslipidaemias

Catapano, Alberico L., Reiner, Željko, De Backer, Guy, Graham, Ian, Taskinen, Marja-Riitta, Wiklund, Olov, Agewall, Stefan, Alegria, Eduardo +10 more·2011·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2011.06.028

Cites (435)

Items 201–400 of 435

  1. Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
    Cooney, Marie Therese, Dudina, Alexandra L., Graham, Ian M. · 2009 · Journal of the American College of Cardiology
  2. Relative risk of cardiovascular disease among people living with <scp>HIV</scp> : a systematic review and meta‐analysis
    Islam, FM, Wu, J, Jansson, J, Wilson, DP · 2012 · HIV Medicine
  3. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
    McKenney, James M., Davidson, Michael H., Jacobson, Terry A., Guyton, John R. · 2006 · The American Journal of Cardiology
  4. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial
    Lewis, Sandra J., Moye, Lemuel A., Sacks, Frank M., Johnstone, David E., Timmis, Gerald, Mitchell, Jayne, Limacher, Marian, Kell, Sherron, Glasser, Stephen P., Grant, Jane et al. · 1998 · Annals of Internal Medicine
  5. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
    Neil, A., Cooper, J., Betteridge, J., Capps, N., McDowell, I., Durrington, P., Seed, M., Humphries, S. E., on behalf of the Simon Broome Familial Hyperlipidaemia Register Group · 2008 · European Heart Journal
  6. Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
    Mills, Edward J., Rachlis, Beth, Wu, Ping, Devereaux, Philip J., Arora, Paul, Perri, Dan · 2008 · Journal of the American College of Cardiology
  7. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S
    Ballantyne, Christie M., Olsson, Anders G., Cook, Thomas J., Mercuri, Michele F., Pedersen, Terje R., Kjekshus, John · 2001 · Circulation
  8. Safety considerations with fibrate therapy
    Davidson, Michael H., Armani, Annemarie, McKenney, James M., Jacobson, Terry A. · 2007 · The American Journal of Cardiology
  9. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
    Gaudet, D, Méthot, J, Déry, S, Brisson, D, Essiembre, C, Tremblay, G, Tremblay, K, de Wal, J, Twisk, J, van den Bulk, N et al. · 2013 · Gene Therapy
  10. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial
    Wolever, Thomas MS, Tosh, Susan M, Gibbs, Alison L, Brand-Miller, Jennie, Duncan, Alison M, Hart, Valerie, Lamarche, Benoît, Thomson, Barbara A, Duss, Ruedi, Wood, Peter J · 2010 · The American Journal of Clinical Nutrition
  11. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin
    Jones, Peter H., Davidson, Michael H. · 2005 · The American Journal of Cardiology
  12. Análisis crítico de un artículo Las estatinas reducen la morbi-mortalidad en pacientes de alto riesgo cardiovascular: Heart Protection Study Collaborative Group. (HPS). Lancet 2002; 360: 7-22.
    Tomás Pantoja C, Luz María Letelier S · 2003 · Revista médica de Chile
  13. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
    Kjekshus, John, Pedersen, Terje R., Olsson, Anders G., Færgeman, Ole, Pyörälä, Kalevi · 1997 · Journal of Cardiac Failure
  14. Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
    Davidson, Michael H., Stein, Evan A., Bays, Harold E., Maki, Kevin C., Doyle, Ralph T., Shalwitz, Robert A., Ballantyne, Christie M., Ginsberg, Henry N. · 2007 · Clinical Therapeutics
  15. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
    Mora, Samia, Szklo, Moyses, Otvos, James D., Greenland, Philip, Psaty, Bruce M., Goff, David C., O’Leary, Daniel H., Saad, Mohammed F., Tsai, Michael Y., Sharrett, A. Richey · 2007 · Atherosclerosis
  16. Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery
    Schouten, Olaf, Boersma, Eric, Hoeks, Sanne E., Benner, Robbert, van Urk, Hero, van Sambeek, Marc R.H.M., Verhagen, Hence J.M., Khan, Nisar A., Dunkelgrun, Martin, Bax, Jeroen J. et al. · 2009 · New England Journal of Medicine
  17. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial
    Heart Protection Study Collaborative Group · 2011 · The Lancet
  18. Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age: The Coronary Artery Risk Development in (Young) Adults (CARDIA) Study
    Liu, Kiang, Daviglus, Martha L., Loria, Catherine M., Colangelo, Laura A., Spring, Bonnie, Moller, Arlen C., Lloyd-Jones, Donald M. · 2012 · Circulation
  19. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials
    Abumweis, SuhadS., Barake, Roula, Jones, PeterJH · 2008 · Food &amp; Nutrition Research
  20. Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
    Robinson, Jennifer G., Wang, Songfeng, Smith, Brian J., Jacobson, Terry A. · 2009 · Journal of the American College of Cardiology
  21. Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study
    Kavousi, Maryam, Elias-Smale, Suzette, Rutten, Joost H.W., Leening, Maarten J.G., Vliegenthart, Rozemarijn, Verwoert, Germaine C., Krestin, Gabriel P., Oudkerk, Matthijs, de Maat, Moniek P.M., Leebeek, Frank W.G. et al. · 2012 · Annals of Internal Medicine
  22. Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
    Bays, Harold E., Ballantyne, Christie M., Kastelein, John J., Isaacsohn, Jonathan L., Braeckman, Rene A., Soni, Paresh N. · 2011 · The American Journal of Cardiology
  23. Early and Late Benefits of High-Dose Atorvastatin in Patients With Acute Coronary Syndromes
    Ray, Kausik K., Cannon, Christopher P., McCabe, Carolyn H., Cairns, Richard, Tonkin, Andrew M., Sacks, Frank M., Jackson, Graham, Braunwald, Eugene · 2005 · Journal of the American College of Cardiology
  24. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
    Banegas, J. R., Lopez-Garcia, E., Dallongeville, J., Guallar, E., Halcox, J. P., Borghi, C., Masso-Gonzalez, E. L., Jimenez, F. J., Perk, J., Steg, P. G. et al. · 2011 · European Heart Journal
  25. Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
    Cholesterol Treatment Trialists' (CTT) Collaboration · 2012 · PLoS ONE
  26. A systematic review and meta-analysis on the therapeutic equivalence of statins: <i>Therapeutic equivalence of statins</i>
    Weng, T.-C., Yang, Y.-H. Kao, Lin, S.-J., Tai, S.-H. · 2010 · Journal of Clinical Pharmacy and Therapeutics
  27. Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
    Ballantyne, Christie M., Bays, Harold E., Kastelein, John J., Stein, Evan, Isaacsohn, Jonathan L., Braeckman, Rene A., Soni, Paresh N. · 2012 · The American Journal of Cardiology
  28. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials
    Mills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., Briel, M. · 2011 · QJM
  29. Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
    Paul W. Ladenson, Jens D. Kristensen, E. Chester Ridgway, ANDERS G. OLSSON, Bo Carlsson, Irwin L. Klein, John D. Baxter, Bo Angelin · 2010 · New England Journal of Medicine
  30. Interventions to improve adherence to lipid-lowering medication
    van Driel, Mieke L, Morledge, Michael D, Ulep, Robin, Shaffer, Johnathon P, Davies, Philippa, Deichmann, Richard · 2016 · Cochrane Database of Systematic Reviews
  31. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
    Suetonia C. Palmer, Sankar Dass Navaneethan, Jonathan C. Craig, David Wayne Johnson, Vlado Perkovic, Jörgen Hegbrant, Giovanni FM Strippoli · 2014 · Cochrane Database of Systematic Reviews
  32. Developing and testing the health literacy universal precautions toolkit
    Darren A. DeWalt, Kimberly A. Broucksou, Victoria Hawk, Cindy Brach, Ashley B. Hink, Rima R. Rudd, Leigh F. Callahan · 2011 · Nursing Outlook
  33. Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
    Mann, Devin M, Woodward, Mark, Muntner, Paul, Falzon, Louise, Kronish, Ian · 2010 · Annals of Pharmacotherapy
  34. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension
    K Pyörälä, G DeBacker, Ian D. Graham, Philip Alexander Poole-Wilson, David Alexander Wood · 1994 · Atherosclerosis
  35. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
    SHARP Collaborative Group · 2010 · American Heart Journal
  36. Systematic review and meta‐analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors
    Santos, F. L., Esteves, S. S., da Costa Pereira, A., Yancy Jr, W. S., Nunes, J. P. L. · 2012 · Obesity Reviews
  37. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
    Saito, Yasushi, Yokoyama, Mitsuhiro, Origasa, Hideki, Matsuzaki, Masunori, Matsuzawa, Yuji, Ishikawa, Yuichi, Oikawa, Shinichi, Sasaki, Jun, Hishida, Hitoshi, Itakura, Hiroshige et al. · 2008 · Atherosclerosis
  38. Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention
    Di Sciascio, Germano, Patti, Giuseppe, Pasceri, Vincenzo, Gaspardone, Achille, Colonna, Giuseppe, Montinaro, Antonio · 2009 · Journal of the American College of Cardiology
  39. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction
    Lu, Zongliang, Kou, Wenrong, Du, Baomin, Wu, Yangfeng, Zhao, Shuiping, Brusco, Osvaldo A., Morgan, John M., Capuzzi, David M. · 2008 · The American Journal of Cardiology
  40. Effects of dietary fructose on plasma lipids in healthy subjects
    John P. Bantle, Susan K. Raatz, William T. B. Thomas, Angeliki Georgopoulos · 2000 · American Journal of Clinical Nutrition
  41. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
    Grundy, Scott M., Vega, Gloria L., Yuan, Zhong, Battisti, Wendy P., Brady, William E., Palmisano, Joanne · 2005 · The American Journal of Cardiology
  42. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement
    D. Kolovou, Genovefa, P. Mikhailidis, Dimitri, Kovar, Jan, Lairon, Dennis, G. Nordestgaard, Borge, Chye Ooi, Teik, Perez-Martinez, Pablo, Bilianou, Helen, Anagnostopoulou, Katherine, Panotopoulos, George · 2011 · Current Vascular Pharmacology
  43. Statins for the primary prevention of cardiovascular disease
    Fiona C. Taylor, Kirsten J. Ward, Theresa HM Moore, Margaret Burke, George Davey Smith, Juan Pablo Casas, Shah B J Ebrahim · 2011 · Cochrane Database of Systematic Reviews
  44. Cardiovascular morbidity in psoriatic arthritis
    Gladman, D D, Ang, M, Su, L, Tom, B D M, Schentag, C T, Farewell, V T · 2009 · Annals of the Rheumatic Diseases
  45. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials
    Bazzano, L.A., Thompson, A.M., Tees, M.T., Nguyen, C.H., Winham, D.M. · 2011 · Nutrition, Metabolism and Cardiovascular Diseases
  46. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study
    Wei Li, J Wang, P Thompson, S Wong, A D Struthers, Thomas MacLennan MacDonald · 2002 · Heart
  47. Statin Therapy and the Risk of Intracerebral Hemorrhage: A Meta-Analysis of 31 Randomized Controlled Trials
    McKinney, James S., Kostis, William J. · 2012 · Stroke
  48. Report of the national heart, lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions
    Marcovina, Santica M, Koschinsky, Marlys L, Albers, John J, Skarlatos, Sonia · 2003 · Clinical Chemistry
  49. Contraceptive hormone use and cardiovascular disease
    Shufelt, Chrisandra L., Bairey Merz, C. Noel · 2009 · Journal of the American College of Cardiology
  50. Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
    Chasman, Daniel I., Giulianini, Franco, MacFadyen, Jean, Barratt, Bryan J., Nyberg, Fredrik, Ridker, Paul M · 2012 · Circulation: Cardiovascular Genetics
  51. Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
    Wei, Melissa Y., Jacobson, Terry A. · 2011 · Current Atherosclerosis Reports
  52. Reduction of Stroke Events With Pravastatin
    Robert P. Byington, Barry R. Davis, Jonathan F. Plehn, Harvey Douglas White, Jennifer Baker, Stuart M. Cobbe, James Shepherd · 2001 · Circulation
  53. Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
    Becker, David J., Gordon, Ram Y., Halbert, Steven C., French, Benjamin, Morris, Patti B., Rader, Daniel J. · 2009 · Annals of Internal Medicine
  54. Severe hypertriglyceridemia and pancreatitis: presentation and management
    Ewald, Nils, Hardt, Philip D, Kloer, Hans-Ulrich · 2009 · Current Opinion in Lipidology
  55. Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
    Bruckert, Eric, Labreuche, Julien, Amarenco, Pierre · 2010 · Atherosclerosis
  56. Cholesterol Reduction Yields Clinical Benefit: A New Look at Old Data
    Gould, A. Lawrence, Rossouw, Jacques E., Santanello, Nancy C., Heyse, Joseph F., Furberg, Curt D. · 1995 · Circulation
  57. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
    Thomas Andrew Gaziano, Lionel Henry Opie, Milton C. Weinstein · 2006 · The Lancet
  58. Drug Treatment of Hyperlipidemia in Women
    Walsh, Judith M. E. · 2004 · JAMA
  59. Safety considerations with niacin therapy
    Guyton, John R., Bays, Harold E. · 2007 · The American Journal of Cardiology
  60. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
    Humphries, S E, Whittall, R A, Hubbart, C S, Maplebeck, S, Cooper, J A, Soutar, A K, Naoumova, R, Thompson, G R, Seed, M, Durrington, P N et al. · 2006 · Journal of Medical Genetics
  61. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
    Björck, Lena, Rosengren, Annika, Bennett, Kathleen, Lappas, George, Capewell, Simon · 2009 · European Heart Journal
  62. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review
    Jacobson, Terry A., Glickstein, Sara B., Rowe, Jonathan D., Soni, Paresh N. · 2012 · Journal of Clinical Lipidology
  63. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
    Fruchart, Jean-Charles, Sacks, Frank M, Hermans, Michel P, Assmann, Gerd, Brown, W Virgil, Ceska, Richard, Chapman, M John, Dodson, Paul M, Fioretto, Paola, Ginsberg, Henry N et al. · 2008 · Diabetes and Vascular Disease Research
  64. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States
    Goldstein, Benjamin I, Fagiolini, Andrea, Houck, Patricia, Kupfer, David J · 2009 · Bipolar Disorders
  65. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
    Barter, Philip J., Brandrup-Wognsen, Gunnar, Palmer, Mike K., Nicholls, Stephen J. · 2010 · Journal of Lipid Research
  66. The epidemiology of excess mortality in people with mental illness
    Lawrence, David, Kisely, Stephen, Pais, Joanne · 2010 · The Canadian Journal of Psychiatry
  67. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial
    Glynn, Robert J., Koenig, Wolfgang, Nordestgaard, Børge G., Shepherd, James, Ridker, Paul M · 2010 · Annals of Internal Medicine
  68. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies
    THOMPSON, A., DANESH, J. · 2006 · Journal of Internal Medicine
  69. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
    Cooney, M.T., Dudina, A., De Bacquer, D., Wilhelmsen, L., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., Thomsen, T. et al. · 2009 · Atherosclerosis
  70. Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function
    Lee, Justin M.S., Robson, Matthew D., Yu, Ly-Mee, Shirodaria, Cheerag C., Cunnington, Colin, Kylintireas, Ilias, Digby, Janet E., Bannister, Thomas, Handa, Ashok, Wiesmann, Frank et al. · 2009 · Journal of the American College of Cardiology
  71. Meta-Analysis: The Effect of Statins on Albuminuria
    Kevin Douglas, Patrick G. O’Malley, Jeffrey L. Jackson · 2006 · Annals of Internal Medicine
  72. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis
    Maeda, Kenji, Noguchi, Yoshinori, Fukui, Tsuguya · 2003 · Preventive Medicine
  73. Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis
    Lee, Meng, Saver, Jeffrey L., Towfighi, Amytis, Chow, Jessica, Ovbiagele, Bruce · 2011 · Atherosclerosis
  74. Novel Approaches for Preventing or Limiting Events (Naples) II Trial
    Briguori, Carlo, Visconti, Gabriella, Focaccio, Amelia, Golia, Bruno, Chieffo, Alaide, Castelli, Alfredo, Mussardo, Marco, Montorfano, Matteo, Ricciardelli, Bruno, Colombo, Antonio · 2009 · Journal of the American College of Cardiology
  75. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
    Kotseva, Komelia, Wood, David, De Backer, Guy, De Bacquer, Dirk, Pyörälä, Kalevi, Reiner, Željko, Keil, Ulrich, EUROASPIRE Study Group · 2010 · European Journal of Cardiovascular Prevention &amp; Rehabilitation
  76. Familial hypercholesterolaemia: summary of NICE guidance
    Anthony S. Wierzbicki, Steve Eric Humphries, Rubin Minhas, on behalf of the Guideline Development Group · 2008 · BMJ
  77. Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE)
    Deedwania, Prakash, Stone, Peter H., Bairey Merz, C. Noel, Cosin-Aguilar, Juan, Koylan, Nevres, Luo, Don, Ouyang, Pamela, Piotrowicz, Ryszard, Schenck-Gustafsson, Karin, Sellier, Philippe et al. · 2007 · Circulation
  78. Statins for the treatment of dementia
    Bernadette McGuinness, David Craig, Roger Alan Bullock, Reem Saleem Malouf, Peter Passmore · 2014 · Cochrane Database of Systematic Reviews
  79. Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol &lt;50 mg/dl With Rosuvastatin
    Hsia, Judith, MacFadyen, Jean G., Monyak, John, Ridker, Paul M. · 2011 · Journal of the American College of Cardiology
  80. Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
    Chapman, M. John, Redfern, Jan S., McGovern, Mark E., Giral, Philippe · 2010 · Pharmacology &amp; Therapeutics
  81. Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)
    Canner, Paul L., Furberg, Curt D., Terrin, Michael L., McGovern, Mark E. · 2005 · The American Journal of Cardiology
  82. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial
    Hunt, David, Young, Peta, Simes, John, Hague, Wendy, Mann, Stewart, Owensby, Dwain, Lane, Geoffrey, Tonkin, Andrew, for the LIPID Investigators · 2001 · Annals of Internal Medicine
  83. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
    Villines, Todd C., Stanek, Eric J., Devine, Patrick J., Turco, Mark, Miller, Michael, Weissman, Neil J., Griffen, Len, Taylor, Allen J. · 2010 · Journal of the American College of Cardiology
  84. Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?
    Cooney, Marie Therese, Dudina, Alexandra, D'Agostino, Ralph, Graham, Ian M. · 2010 · Circulation
  85. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs
    Dragomir, Alice, Côté, Robert, Roy, Louise, Blais, Lucie, Lalonde, Lyne, Bérard, Anick, Perreault, Sylvie · 2010 · Medical Care
  86. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study
    Ilanne-Parikka, Pirjo, Eriksson, Johan G., Lindström, Jaana, Peltonen, Markku, Aunola, Sirkka, Hämäläinen, Helena, Keinänen-Kiukaanniemi, Sirkka, Laakso, Mauri, Valle, Timo T., Lahtela, Jorma et al. · 2008 · Diabetes Care
  87. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation
    Ferrario, Marco, Chiodini, Paolo, Chambless, Lloyd E, Cesana, Giancarlo, Vanuzzo, Diego, Panico, Salvatore, Sega, Roberto, Pilotto, Lorenza, Palmieri, Luigi, Giampaoli, Simona · 2005 · International Journal of Epidemiology
  88. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV<sup>*</sup>
    Lundgren, JD, Battegay, M, Behrens, G, De Wit, S, Guaraldi, G, Katlama, C, Martinez, E, Nair, D, Powderly, WG, Reiss, P et al. · 2008 · HIV Medicine
  89. Lipid-lowering for peripheral arterial disease of the lower limb
    Phyu Phyu Aung, Heather Maxwell, Ruth Gillian Jepson, Jackie F. Price, Gillian C. Leng · 2007 · Cochrane Database of Systematic Reviews
  90. Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis
    Kotwal, Sradha, Jun, Min, Sullivan, David, Perkovic, Vlado, Neal, Bruce · 2012 · Circulation: Cardiovascular Quality and Outcomes
  91. Cardiovascular risk factor trends and options for reducing future coronary heart disease mortality in the United States of America
    Capewell, Simon, Ford, Earl S, Croft, Janet B, Critchley, Julia A, Greenlund, Kurt J, Labarthe, Darwin R · 2010 · Bulletin of the World Health Organization
  92. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003–2010
    Gale, C. P., Cattle, B. A., Woolston, A., Baxter, P. D., West, T. H., Simms, A. D., Blaxill, J., Greenwood, D. C., Fox, K. A. A., West, R. M. · 2012 · European Heart Journal
  93. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects
    Rivellese, Angela A, Maffettone, Ada, Vessby, Bengt, Uusitupa, Matti, Hermansen, Kjeld, Berglund, Lars, Louheranta, Anne, Meyer, Barbara J, Riccardi, Gabriele · 2003 · Atherosclerosis
  94. Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)
    Ballantyne, Christie M., Weiss, Robert, Moccetti, Tiziano, Vogt, Anja, Eber, Bernd, Sosef, Froukje, Duffield, Emma · 2007 · The American Journal of Cardiology
  95. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials
    Musa-Veloso, Kathy, Poon, Theresa H., Elliot, Julie Ann, Chung, Catherine · 2011 · Prostaglandins, Leukotrienes and Essential Fatty Acids
  96. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis
    Bruckert, Eric, Labreuche, Julien, Deplanque, Dominique, Touboul, Pierre-Jean, Amarenco, Pierre · 2011 · Journal of Cardiovascular Pharmacology
  97. Effects of Fibrates in Kidney Disease
    Jun, Min, Zhu, Bin, Tonelli, Marcello, Jardine, Meg J., Patel, Anushka, Neal, Bruce, Liyanage, Thaminda, Keech, Anthony, Cass, Alan, Perkovic, Vlado · 2012 · Journal of the American College of Cardiology
  98. Serum cholesterol response to dietary cholesterol
    Ancel B. Keys · 1984 · American Journal of Clinical Nutrition
  99. Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention
    Giuseppe Patti, Christopher Paul Cannon, Sabina A. Murphy, Simona Mega, Vincenzo Pasceri, Carlo Briguori, Antonio Colombo, Kyeong Ho Yun, Myung Ho Jeong, Jung‐Sun Kim et al. · 2011 · Circulation
  100. Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware!
    Gordon, Ram Y., Cooperman, Tod, Obermeyer, William, Becker, David J. · 2010 · Archives of Internal Medicine
  101. Efficacy of High-Dose Atorvastatin Loading Before Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
    Kim, Jung-Sun, Kim, Jaedeok, Choi, Donghoon, Lee, Chan Joo, Lee, Sang Hak, Ko, Young-Guk, Hong, Myeong-Ki, Kim, Byoung-Keuk, Oh, Seong Jin, Jeon, Dong Woon et al. · 2010 · JACC: Cardiovascular Interventions
  102. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 Study
    Scirica, Benjamin M., Morrow, David A., Cannon, Christopher P., Ray, Kausik K., Sabatine, Marc S., Jarolim, Petr, Shui, Amy, McCabe, Carolyn H., Braunwald, Eugene · 2006 · Journal of the American College of Cardiology
  103. Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy
    Waters, David D., Ho, Jennifer E., Boekholdt, S. Matthijs, DeMicco, David A., Kastelein, John J.P., Messig, Michael, Breazna, Andrei, Pedersen, Terje R. · 2013 · Journal of the American College of Cardiology
  104. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease
    Tedeschi-Reiner, Eugenia, Strozzi, Maja, Skoric, Bosko, Reiner, Zeljko · 2005 · The American Journal of Cardiology
  105. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome
    Liu, Jing, Grundy, Scott M., Wang, Wei, Smith, Sidney C., Lena Vega, Gloria, Wu, Zhaosu, Zeng, Zhechun, Wang, Wenhua, Zhao, Dong · 2007 · American Heart Journal
  106. Cardiovascular risk estimation in older persons: SCORE O.P
    Cooney, Marie Therese, Selmer, Randi, Lindman, Anja, Tverdal, Aage, Menotti, Alessandro, Thomsen, Troels, DeBacker, Guy, De Bacquer, Dirk, Tell, Grethe S, Njolstad, Inger et al. · 2016 · European Journal of Preventive Cardiology
  107. Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure: Subgroup Analysis of the Treating to New Targets (TNT) Study
    Khush, Kiran K., Waters, David D., Bittner, Vera, Deedwania, Prakash C., Kastelein, John J.P., Lewis, Sandra J., Wenger, Nanette K. · 2007 · Circulation
  108. Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined Hyperlipidemia
    Heiner K. Berthold, Susanne Unverdorben, Ralf Degenhardt, Michael Bulitta, Ioanna Gouni‐Berthold · 2006 · JAMA
  109. Basic data concerning associated coronary disease in peripheral vascular patients
    Hertzer, Norman R. · 1987 · Annals of Vascular Surgery
  110. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study
    Langsted, Anne, Nordestgaard, Børge G · 2011 · Clinical Chemistry
  111. Effect of pravastatin in people with diabetes and chronic kidney disease
    Tonelli, Marcello, Keech, Anthony, Shepherd, Jim, Sacks, Frank, Tonkin, Andrew, Packard, Chris, Pfeffer, Marc, Simes, John, Isles, Chris, Furberg, Curt et al. · 2005 · Journal of the American Society of Nephrology
  112. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
    Glass, TR, Ungsedhapand, C, Wolbers, M, Weber, R, Vernazza, PL, Rickenbach, M, Furrer, H, Bernasconi, E, Cavassini, M, Hirschel, B et al. · 2006 · HIV Medicine
  113. β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials
    AbuMweis, S S, Jew, S, Ames, N P · 2010 · European Journal of Clinical Nutrition
  114. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells
    Sidaway, James E., Davidson, Robert G., McTaggart, Fergus, Orton, Terry C., Scott, Robert C., Smith, Graham J., Brunskill, Nigel J. · 2004 · Journal of the American Society of Nephrology
  115. Untitled work
    Veenkamp · 2002 · 10.1161/hq0202.104059
  116. Low glycaemic index diets and blood lipids: a systematic review and meta-analysis of randomised controlled trials
    Goff, L.M., Cowland, D.E., Hooper, L., Frost, G.S. · 2013 · Nutrition, Metabolism and Cardiovascular Diseases
  117. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
    McKenney, James M., Jones, Peter H., Bays, Harold E., Knopp, Robert H., Kashyap, Moti L., Ruoff, Gary E., McGovern, Mark E. · 2007 · Atherosclerosis
  118. Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey
    Reiner, Željko, Sonicki, Zdenko, Tedeschi-Reiner, Eugenia · 2010 · Atherosclerosis
  119. HMG CoA reductase inhibitors (statins) for kidney transplant recipients
    Suetonia C. Palmer, Sankar Dass Navaneethan, Jonathan C. Craig, Vlado Perkovic, David Wayne Johnson, Sagar U Nigwekar, Jörgen Hegbrant, Giovanni FM Strippoli · 2014 · Cochrane Database of Systematic Reviews
  120. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel
    Chodick, Gabriel, Shalev, Varda, Gerber, Yariv, Heymann, Anthony D., Silber, Haim, Simah, Virginia, Kokia, Ehud · 2008 · Clinical Therapeutics
  121. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis
    Petretta, Mario, Costanzo, Pierluigi, Perrone-Filardi, Pasquale, Chiariello, Massimo · 2010 · International Journal of Cardiology
  122. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease
    Wenger, Nanette K., Lewis, Sandra J., Herrington, David M., Bittner, Vera, Welty, Francine K., for the Treating to New Targets Study Steering Committee and Investigators · 2007 · Annals of Internal Medicine
  123. Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities
    Todd Christopher Rideout · 2008 · Vascular Health and Risk Management
  124. Untitled work
    Robinson · 2012 · 10.1016/j.amjcard.2012.07.007
  125. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease
    McDermott, Mary McGrae, Mandapat, Aimee Luna, Moates, Amanda, Albay, Monique, Chiou, Eric, Celic, Lillian, Greenland, Philip · 2003 · Archives of Internal Medicine
  126. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
    Onat, Altan, Hergenç, Gülay, Sansoy, Vedat, Fobker, Manfred, Ceyhan, Köksal, Toprak, Sadık, Assmann, Gerd · 2003 · Atherosclerosis
  127. Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes
    Vuppalanchi, Raj, Chalasani, Naga, Teal, Evegenia · 2005 · The American Journal of the Medical Sciences
  128. Alcohol Consumption and Risk for Coronary Heart Disease among Men with Hypertension
    Joline W. J. Beulens, Eric B. Rimm, Alberto Ascherio, Donna L. Spiegelman, H. Hendriks, Kenneth Jay Mukamal · 2007 · Annals of Internal Medicine
  129. Selecting target conditions for quality of care improvement in vulnerable older adults
    Sloss, Elizabeth M., Solomon, David H., Shekelle, Paul G., Young, Roy T., Saliba, Debra, MacLean, Catherine H., Rubenstein, Laurence Z., Schnelle, John F., Kamberg, Caren J., Wenger, Neil S. · 2000 · Journal of the American Geriatrics Society
  130. Colesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence
    Fonseca, Vivian A., Handelsman, Yehuda, Staels, Bart · 2010 · Diabetes, Obesity and Metabolism
  131. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
    MAS, R, CASTANO, G, ILLNAIT, J, FERNANDEZ, L, FERNANDEZ, J, ALEMAN, C, PONTIGAS, V, LESCAY, M · 1999 · Clinical Pharmacology &amp; Therapeutics
  132. Statin safety: an assessment using an administrative claims database
    Cziraky, Mark J., Willey, Vincent J., McKenney, James M., Kamat, Siddhesh A., Fisher, Maxine D., Guyton, John R., Jacobson, Terry A., Davidson, Michael H. · 2006 · The American Journal of Cardiology
  133. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
    Packard, Chris J · 2006 · Current Opinion in Lipidology
  134. Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies
    Marie Therese Cooney, Alexandra L. Dudina, Peter Hynes Whincup, Simon Capewell, Alessandro Menotti, Pekka Jousilahti, Inger Njølstad, Р. Г. Оганов, Troels Frølund Thomsen, Aage Tverdal et al. · 2009 · European Journal of Cardiovascular Prevention & Rehabilitation
  135. Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis
    Kang, Sheng, Wu, Yangfeng, Li, Xian · 2004 · Atherosclerosis
  136. Advanced method for the identification of patients with inherited hypercholesterolemia
    Defesche, Joep, Lansberg, Peter, Umans-Eckenhausen, Marina, Kastelein, John · 2004 · Seminars in Vascular Medicine
  137. Do Lipids, Blood Pressure, Diabetes, and Smoking Confer Equal Risk of Myocardial Infarction in Women as in Men? the Reykjavik Study
    Lilja Sigrún Jónsdóttir, Nikulás Sigfússon, Vilmundur G. Gudnason, Helgi Sigvaldason, G. Thorgeirsson · 2002 · European Journal of Cardiovascular Prevention & Rehabilitation
  138. Low glycaemic index diets for coronary heart disease
    Kelly, Sarah AM, Frost, Gary, Whittaker, Victoria, Summerbell, Carolyn D · 2004 · Cochrane Database of Systematic Reviews
  139. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    David F Blackburn, Roy T Dobson, James L. Blackburn, Thomas W. Wilson, Mary Rose Stang, William Semchuk · 2005 · PubMed
  140. How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators
    Cooney, Marie Therese, Dudina, Alexandra, De Bacquer, Dirk, Fitzgerald, Anthony, Conroy, Ronan, Sans, Susana, Menotti, Alessandro, De Backer, Guy, Jousilahti, Pekka, Keil, Ulrich et al. · 2009 · European Journal of Cardiovascular Prevention &amp; Rehabilitation
  141. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins
    Cesare Riccardo Sirtori, Claudio Galli, James W. Anderson, Anna Arnoldi · 2008 · Atherosclerosis
  142. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
    Leonardo Calza, Roberto Manfredi, Francesco Chiodo · 2003 · AIDS
  143. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis
    Mihas, Constantinos, D. Kolovou, Genovefa, P. Mikhailidis, Dimitri, Kovar, Jan, Lairon, Dennis, G. Nordestgaard, Borge, Chye Ooi, Teik, Perez-Martinez, Pablo, Bilianou, Helen, Anagnostopoulou, Katherine et al. · 2011 · Current Vascular Pharmacology
  144. Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients
    De Natale, Claudia, Annuzzi, Giovanni, Bozzetto, Lutgarda, Mazzarella, Raffaella, Costabile, Giuseppina, Ciano, Ornella, Riccardi, Gabriele, Rivellese, Angela A. · 2009 · Diabetes Care
  145. Statin safety: an appraisal from the adverse event reporting system
    Davidson, Michael H., Clark, John A., Glass, Lucas M., Kanumalla, Anju · 2006 · The American Journal of Cardiology
  146. Weighing the benefits of high-dose simvastatin against the risk of myopathy
    Egan, Amy, Colman, Eric · 2011 · New England Journal of Medicine
  147. Characteristics of the Diet Patterns Tested in the Optimal Macronutrient Intake Trial to Prevent Heart Disease (OmniHeart): Options for a Heart-Healthy Diet
    Swain, Janis F., McCarron, Phyllis B., Hamilton, Eileen F., Sacks, Frank M., Appel, Lawrence J. · 2008 · Journal of the American Dietetic Association
  148. Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies
    Takagi, H., Yamamoto, H., Iwata, K., Goto, S., Umemoto, T. · 2012 · European Journal of Vascular and Endovascular Surgery
  149. A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose
    Lindkvist, Björn, Appelros, Stefan, Regnér, Sara, Manjer, Jonas · 2012 · Pancreatology
  150. Review: Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis
    Mitchell, Alex J, Lord, Oliver · 2010 · Journal of Psychopharmacology
  151. Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25–74 between the years 1981 and 2006
    Aspelund, Thor, Gudnason, Vilmundur, Magnusdottir, Bergrun Tinna, Andersen, Karl, Sigurdsson, Gunnar, Thorsson, Bolli, Steingrimsdottir, Laufey, Critchley, Julia, Bennett, Kathleen, O'Flaherty, Martin et al. · 2010 · PLoS ONE
  152. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease
    Haase, Christiane L., Tybjærg-Hansen, Anne, Grande, Peer, Frikke-Schmidt, Ruth · 2010 · The Journal of Clinical Endocrinology &amp; Metabolism
  153. Drug Therapy in the Heart Transplant Recipient: Part IV: Drug–Drug Interactions
    Page, Robert L., Miller, Geraldine G., Lindenfeld, JoAnn · 2005 · Circulation
  154. Combined therapy in the treatment of dyslipidemia
    Reiner, Željko · 2010 · Fundamental &amp; Clinical Pharmacology
  155. Which interventions offer best value for money in primary prevention of cardiovascular disease
    Cobiac, Linda J., Magnus, Anne, Lim, Stephen, Barendregt, Jan J., Carter, Rob, Vos, Theo · 2012 · PLoS ONE
  156. The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover
    Seed, Mary, O'Connor, Bernadette, Perombelon, Nicholas, O'Donnell, Martina, Reaveley, David, Knight, Brian L. · 1993 · Atherosclerosis
  157. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?
    Paraskevas, K.I., Liapis, C.D., Hamilton, G., Mikhailidis, D.P. · 2006 · European Journal of Vascular and Endovascular Surgery
  158. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia
    Johansen, Christopher T., Wang, Jian, Lanktree, Matthew B., McIntyre, Adam D., Ban, Matthew R., Martins, Rebecca A., Kennedy, Brooke A., Hassell, Reina G., Visser, Maartje E., Schwartz, Stephen M. et al. · 2011 · Arteriosclerosis, Thrombosis, and Vascular Biology
  159. Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)
    Charlton-Menys, Valentine, Betteridge, D John, Colhoun, Helen, Fuller, John, France, Michael, Hitman, Graham A, Livingstone, Shona J, Neil, H Andrew W, Newman, Connie B, Szarek, Michael et al. · 2009 · Clinical Chemistry
  160. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes
    on behalf of the FIELD study investigators, Taskinen, M.-R., Barter, P. J., Ehnholm, C., Sullivan, D. R., Mann, K., Simes, J., Best, J. D., Hamwood, S., Keech, A. C. · 2010 · Diabetologia
  161. The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels
    Mooradian, Arshag D., Haas, Michael J., Wong, Norman C. W. · 2006 · Endocrine Reviews
  162. Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
    Guyton, John R., Brown, B. Greg, Fazio, Sergio, Polis, Adam, Tomassini, Joanne E., Tershakovec, Andrew M. · 2008 · Journal of the American College of Cardiology
  163. A Critical Evaluation of the Role of Soy Protein and Isoflavone Supplementation in the Control of Plasma Cholesterol Concentrations
    Dewell, Antonella, Hollenbeck, Piper L. W., Hollenbeck, Clarie B. · 2006 · The Journal of Clinical Endocrinology &amp; Metabolism
  164. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy
    Giovanni Corrao, Valentino Conti, Luca Giuseppe Merlino, Alberico Luigi Catapano, Giuseppe Mancia · 2010 · Clinical Therapeutics
  165. FDA drug safety communications: a narrative review and clinical considerations for older adults
    Marcum, Zachary A., Vande Griend, Joseph P., Linnebur, Sunny A. · 2012 · The American Journal of Geriatric Pharmacotherapy
  166. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk
    Brown, B. Greg, Zhao, Xue-Qiao · 2008 · The American Journal of Cardiology
  167. The clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patients
    Cherry, Spencer B., Benner, Joshua S., Hussein, Mohamed A., Tang, Simon S.K., Nichol, Michael B. · 2009 · Value in Health
  168. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)
    Murphy, Sabina A., Cannon, Christopher P., Wiviott, Stephen D., de Lemos, James A., Blazing, Michael A., McCabe, Carolyn H., Califf, Robert M., Braunwald, Eugene · 2007 · The American Journal of Cardiology
  169. Effect of statins on the progression of bioprosthetic aortic valve degeneration
    Antonini-Canterin, Francesco, Zuppiroli, Alfredo, Popescu, Bogdan A, Granata, Gianluca, Cervesato, Eugenio, Piazza, Rita, Pavan, Daniela, Nicolosi, Gian Luigi · 2003 · The American Journal of Cardiology
  170. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week multicenter, randomized, double-blind, controlled trial
    Huijgen, Roeland, Abbink, Evertine J., Bruckert, Eric, Stalenhoef, Anton F.H., Imholz, Ben P.M., Durrington, Paul N., Trip, M.D., Eriksson, Mats, Visseren, Frank L.J., Schaefer, Juergen R. et al. · 2010 · Clinical Therapeutics
  171. Rosuvastatin safety: lessons from the FDA review and post-approval surveillance
    Davidson, Michael H · 2004 · Expert Opinion on Drug Safety
  172. Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients
    Van Der Lee, Manon, Sankatsing, Raaj, Schippers, Emile, Vogel, Martin, Fätkenheuer, Gerd, Van Der Ven, Andre, Kroon, Frank, Rockstroh, Jürgen, Wyen, Christoph, Bäumer, Anselm et al. · 2007 · Antiviral Therapy
  173. Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in Studies of a Targeted Risk Reduction Intervention through Defined Exercise I
    Huffman, Kim M., Hawk, Victoria H., Henes, Sarah T., Ocampo, Christine I., Orenduff, Melissa C., Slentz, Cris A., Johnson, Johanna L., Houmard, Joseph A., Samsa, Gregory P., Kraus, William E. et al. · 2012 · American Heart Journal
  174. Medication adherence trends with statins
    Michelle A. Huser, Tamara S. Evans, Val Berger · 2005 · Advances in Therapy
  175. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus
    GOLDBERG, ROBERT J., UROWITZ, MURRAY B., IBAÑEZ, DOMINIQUE, NIKPOUR, MANDANA, GLADMAN, DAFNA D. · 2009 · The Journal of Rheumatology
  176. Statins: an essential component in the management of carotid artery disease
    Paraskevas, Kosmas I., Hamilton, George, Mikhailidis, Dimitri P. · 2007 · Journal of Vascular Surgery
  177. Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials
    Huang, Yubei, Li, Weiqin, Dong, Lili, Li, Ruilai, Wu, Yangfeng · 2013 · Journal of Atherosclerosis and Thrombosis
  178. Pleiotropic Effects of Statins: Evidence Against Benefits Beyond LDL-Cholesterol Lowering
    Pedersen, Terje R. · 2010 · American Journal Cardiovascular Drugs
  179. Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention
    Ordovas, José M · 2009 · The American Journal of Clinical Nutrition
  180. Public perceptions of cardiovascular risk factors in Croatia: The PERCRO survey
    Reiner, Željko, Sonicki, Zdenko, Tedeschi-Reiner, Eugenia · 2010 · Preventive Medicine
  181. Impact of progressive resistance training on lipids and lipoproteins in adults: Another look at a meta-analysis using prediction intervals
    Kelley, George A., Kelley, Kristi S. · 2009 · Preventive Medicine
  182. PASSCLAIM, Process for the Assessment of Scientific Support for Claims on Foods
    Peter John Aggett, JM Antonine, NG Asp, France Bellisle · 2005 · European Journal of Nutrition
  183. Low density lipoprotein cholesterol, statins and cardiovascular events: a meta-analysis
    Genser, Bernd, März, Winfried · 2006 · Clinical Research in Cardiology
  184. Statins for women with polycystic ovary syndrome not actively trying to conceive
    Amit D. Raval, Tamara Hunter, Bronwyn G. A. Stuckey, Roger J Hart · 2011 · Cochrane Database of Systematic Reviews
  185. United Nations' dietary policies to prevent cardiovascular disease
    Mozaffarian, D., Capewell, S. · 2011 · BMJ
  186. Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and significance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel
    1992 · Circulation
  187. The safety of rosuvastatin in comparison with other statins in over 100 000 statin users in UK primary care
    Luis A. García‐Rodríguez, Elvira L Massó-González, Mari-Ann A. Wallander, Saga Johansson · 2008 · Pharmacoepidemiology and Drug Safety
  188. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study
    De Vera, Mary A, Choi, Hyon, Abrahamowicz, Michal, Kopec, Jacek, Goycochea-Robles, Maria Victoria, Lacaille, Diane · 2011 · Annals of the Rheumatic Diseases
  189. Non-pharmacological control of plasma cholesterol levels
    Poli, Andrea, Marangoni, Franca, Paoletti, Rodolfo, Mannarino, Elmo, Lupattelli, Graziana, Notarbartolo, Alberto, Aureli, Paolo, Bernini, Franco, Cicero, Arrigo, Gaddi, Antonio et al. · 2008 · Nutrition, Metabolism and Cardiovascular Diseases
  190. Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate
    Taskinen, Marja-Riitta, Sullivan, David R., Ehnholm, Christian, Whiting, Malcolm, Zannino, Diana, Simes, R. John, Keech, Anthony C., Barter, Philip J. · 2009 · Arteriosclerosis, Thrombosis, and Vascular Biology
  191. Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment
    Gränsbo, Klas, Melander, Olle, Wallentin, Lars, Lindbäck, Johan, Stenestrand, Ulf, Carlsson, Jörg, Nilsson, Jan · 2010 · Journal of the American College of Cardiology
  192. Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials
    Saha, Sandeep A., Arora, Rohit R. · 2010 · International Journal of Cardiology
  193. Combination statin-fibrate therapy: safety aspects
    Franssen, R., Vergeer, M., Stroes, E. S. G., Kastelein, J. J. P. · 2009 · Diabetes, Obesity and Metabolism
  194. Untitled work
    2010 · PubMed
  195. Ezetimibe Alone Reduces Low‐Density Lipoprotein Cholesterol in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy
    David Alain Wohl, David D. Waters, Ross J. Simpson, Susan Richard, Amanda Schnell, Sonia Napravnik, Jessica Keys, Joseph J. Eron, Priscilla Y. Hsue · 2008 · Clinical Infectious Diseases
  196. Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes
    Rivellese, Angela A., Giacco, Rosalba, Annuzzi, Giovanni, De Natale, Claudia, Patti, Lidia, Di Marino, Lucrezia, Minerva, Valentina, Costabile, Giuseppina, Santangelo, Carmela, Masella, Roberta et al. · 2008 · Clinical Nutrition
  197. Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study
    Philippe Latry, Mathiéu Molimard, Bernard Dedieu, Thierry Couffinhal, Bernard Bégaud, Karin Martin‐Latry · 2011 · BMC Cardiovascular Disorders
  198. The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment
    Hyre, Amanda D., Fox, Caroline S., Astor, Brad C., Cohen, Andrew J., Muntner, Paul · 2007 · American Journal of Kidney Diseases
  199. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus
    Thorburn, Christine M., Ward, Michael M. · 2003 · Arthritis &amp; Rheumatism
  200. The use of Meta‐Analysis Risk Estimates for Candidate Genes in Combination to Predict Coronary Heart Disease Risk
    Fotios Drenos, John C. Whittaker, Steve Eric Humphries · 2007 · Annals of Human Genetics